8 completed, 3 unknown, 1 terminated. 12 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 12 | Completed 8, Unknown 3, Terminated 1 |
Follow ESRD: new trials by email Literature Review of ESRD trials Research Report on ESRD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis Fexofenadine, Gabapentin - Uremic Pruritus, Chronic Kidney Disease-associated Pruritus | Phase 4 | Completed | Tanta University | 60 | 2024-07-01 | 2025-04-27 |
| Safety and Efficacy of Canagliflozin in Advanced CKD Invokana 300 mg and 100 mg tablet - ESRD, CKD Stage 4 | Phase 4 | Completed | McGill University Health Centre/Research Institute of the McGill University Health Centre | 34 | 2022-11-24 | 2026-07-13 |
| Pharmacokinetics of JULUCA in Hemodialysis JULUCA 50Mg-25Mg Tablet - HIV/AIDS, ESRD | Phase 4 | Completed | Indiana University | 8 | 2021-04-23 | 2024-06-05 |
| Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated) - ESRD, Influenza Vaccine | Phase 4 | Unknown | Mahidol University | 175 | 2021-03-01 | 2021-11-03 |
| The Impact of Statin Holiday in Dialysis Patients Over 70 Years Old on Mental Function, Physical Function and Frailty discontinue statin - ESRD, Cardiovascular Diseases | Phase 4 | Unknown | Loyola University | 30 | 2018-08-17 | 2019-04-23 |
| Artegraft Versus Propaten Dialysis Grafts Artegraft, Propaten - ESRD, Renal Failure | Phase 4 | Terminated | Kaiser Permanente | 1 | 2014-04-01 | 2019-05-15 |
| Phosphate Kinetic Modeling 2 PKM Algorithm - Hyperphosphatemia, ESRD | Phase 4 | Completed | Fresenius Medical Care North America | 81 | 2010-09-01 | 2014-08-18 |
| The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition double-chamber bag Stay-Safe Balance system, glucose-based dialysis solution - Renal Failure, ESRD | Phase 4 | Completed | Chinese University of Hong Kong | 68 | 2010-09-01 | 2014-09-08 |
| IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients Physioneal, Dianeal, Extraneal - ESRD, Diabetes | Phase 4 | Completed | Vantive Health LLC | 137 | 2008-01-01 | 2025-07-22 |
| Pioglitazone, Body Composition,Insulin Sensitivity and Protein Metabolism in ESRD Pioglitazone - ESRD | Phase 4 | Unknown | Centre Hospitalier Universitaire Vaudois | 16 | 2007-03-01 | 2010-12-06 |
| Donor Dopamine and Initial Graft Function Dopamine infusion to brain dead organ donors - Kidney Transplantation, ESRD | Phase 4 | Completed | Universitätsmedizin Mannheim | 487 | 2004-03-01 | 2009-04-23 |
| Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia Gentamycin/citrate, Minocycline/EDTA - ESRD | Phase 4 | Completed | Henry Ford Health System | 120 | 2003-09-01 | 2006-02-22 |
Kidney Failure, Chronic (12) · Cardiovascular Diseases (2) · Renal Insufficiency (2) · Acquired Immunodeficiency Syndrome (1) · Diabetes Mellitus (1) · Hyperphosphatemia (1) · Influenza, Human (1) · Insulin Resistance (1) · Malnutrition (1) · Pruritus (1) · Renal Insufficiency, Chronic (1)
Chronic Disease (12) · Disease Attributes (12) · Female Urogenital Diseases (12) · Female Urogenital Diseases and Pregnancy Complications (12) · Kidney Diseases (12) · Male Urogenital Diseases (12) · Pathologic Processes (12) · Pathological Conditions, Signs and Symptoms (12) · Urogenital Diseases (12) · Urologic Diseases (12) · Renal Insufficiency, Chronic (11) · Renal Insufficiency (10) · Nutritional and Metabolic Diseases (4) · Metabolic Diseases (3) · Glucose Metabolism Disorders (2)
Antigens, Surface (1) · Canagliflozin (1) · Citric Acid (1) · Gabapentin (1) · Gentamicins (1) · Icodextrin (1) · Influenza Vaccines (1) · Nutrineal (1) · Pioglitazone (1) · Tablets (1) · dolutegravir, rilpivirine drug combination (1) · fexofenadine (1)
Centre Hospitalier Universitaire Vaudois (1) · Chinese University of Hong Kong (1) · Fresenius Medical Care North America (1) · Henry Ford Health System (1) · Indiana University (1) · Kaiser Permanente (1) · Loyola University (1) · Mahidol University (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Tanta University (1) · Universitätsmedizin Mannheim (1) · Vantive Health LLC (1)
United States (5) · Hong Kong (2) · Canada (1) · Egypt (1) · Germany (1) · Russia (1) · Singapore (1) · South Korea (1) · Switzerland (1) · Taiwan (1) · Thailand (1)
Ahmed M Hussein, PhD (1) · Anne Zanchi, MD (1) · Antanole Bearabe, MD (1) · Cheuk Chun Szeto, MD (1) · Detlef Boesebeck, MD (1) · Earl Schuman, MD (1) · Julia Schneider (1) · Mohamed I Hosney, PharmD (1) · Peter Kotanko, MD (1) · Peter Schnuelle, MD (1) · Philip KT Li, MD (1) · Sahar M El-Haggar, PhD (1) · Samir K Gupta, MD (1) · Thomas Mavrakanas, MD (1)
PMID 12138146, PMID 15492943, PMID 19738091, PMID 21996389, PMID 22067309, PMID 25330088, PMID 26510186, PMID 28213388, PMID 29027352, PMID 29994980, PMID 30102825, PMID 39430196, PMID 39761595, PMID 40952584